文献速递痛风与晶体性关节病

膳食与补充ω-3多不饱和脂肪酸对痛风复发性发作风险的影响

Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.
PubMed 文献 · Arthritis Rheumatol · 2019-08-01

基于波士顿大学在线痛风研究(2003–2012年)的病例交叉分析,纳入724例参与者,评估发作前48小时n-3多不饱和脂肪酸(PUFA)摄入与痛风复发风险的关系。调整总嘌呤摄入等因素后,食用≥2份富含n-3 PUFA的鱼与复发风险降低相关(OR 0.74,95%CI 0.54–0.99;P=0.04),而自行补充n-3 PUFA与风险无关(OR 1.01,95%CI 0.63–1.60;P=0.98)。

要点

  • 食用≥2份富含n-3 PUFA的鱼与痛风复发风险降低相关,OR 0.74(95%CI 0.54–0.99)。
  • 自行补充n-3 PUFA与痛风复发风险无关,OR 1.01(95%CI 0.63–1.60)。
  • 上述关联在调整总嘌呤摄入、利尿剂及降尿酸/预防发作药物后成立。

核心结论

  • 调整总嘌呤摄入后,膳食来源的富含n-3 PUFA的鱼摄入与痛风复发风险降低相关,而自行补充n-3 PUFA alone与风险无关。

研究设计与样本

  • 研究采用波士顿大学在线痛风研究(2003年2月至2012年1月)的互联网病例交叉设计,共纳入724例参与者。
  • 参与者在痛风发作期(风险期)和无发作期(对照期)完成前48小时暴露问卷,包括补充剂和饮食。
  • 采用条件logistic回归分析,调整总嘌呤摄入、利尿剂使用及其他降尿酸或预防发作药物(别嘌醇、非甾体抗炎药或秋水仙碱)。

主要发现

  • 724例参与者中85%符合1977年美国风湿病学会原发性痛风急性关节炎分类初步标准。
  • 全部3种补充剂合并的调整OR为1.01(95%CI 0.63–1.60;P=0.98)。
  • 摄入≥2份富含n-3 PUFA的鱼的调整OR为0.74(95%CI 0.54–0.99;P=0.04)。

关键数值与推荐

  • 85%的参与者符合1977年美国风湿病学会原发性痛风急性关节炎分类初步标准。
  • 摄入≥2份富含n-3 PUFA的鱼的调整OR为0.74(95%CI 0.54–0.99;P=0.04)。
  • 全部3种补充剂合并的调整OR为1.01(95%CI 0.63–1.60;P=0.98)。

临床怎么用

  • 对于痛风患者,可考虑建议食用富含n-3 PUFA的鱼以降低复发风险,但需结合总嘌呤摄入管理。
  • 自行补充n-3 PUFA补充剂未显示降低痛风复发风险,不应作为常规推荐用于此目的。

局限性

  • 研究为观察性病例交叉设计,无法确立因果关系。
  • n-3 PUFA补充剂使用比例较低(4.6%),可能影响补充剂相关分析的把握度。
  • 原文指出需在足够把握度的临床试验中进一步研究特定来源和 adequate doses 的n-3 PUFA用于痛风发作预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the relationship between omega-3 polyunsaturated fatty acid (n-3 PUFA) consumption (dietary or supplemental) and risk of gout flares. METHODS: We used data from the Boston University Online Gout Study, an internet-based case-crossover study conducted from February 2003 to January 2012. At the times of gout flares (hazard period) and during gout flare-free periods (control periods), participants completed questionnaires regarding exposures, including supplements and diet, during the preceding 48 hours. We examined the relationship of self-reported n-3 PUFA-rich supplements and fish intake with the risk of recurrent gout flares using conditional logistic regression, adjusting for total purine intake, diuretic use, and other urate-lowering or flare prophylactic medications (allopurinol, nonsteroidal antiinflammatory drugs, or colchicine). RESULTS: Of the 724 participants, 85% met the 1977 American College of Rheumatology preliminary criteria for the classification of the acute arthritis of primary gout. Twenty-two percent of the participants reported some form of n-3 PUFA consumption (supplements, 4.6%; dietary fatty fish, 19%) in the 48 hours preceding a gout flare or flare-free period. The adjusted odds ratios were 1.01 (95% confidence interval [95% CI] 0.63-1.60; P = 0.98) for all 3 supplements combined and 0.74 (95% CI 0.54-0.99; P = 0.04) for consumption of ≥2 n-3 PUFA-rich fish servings. CONCLUSION: Dietary n-3 PUFA-rich fish consumption, when adjusted for total purine intake, was associated with lower risk of recurrent gout flares, whereas n-3 PUFA supplementation alone, as taken in a self-directed manner, was not. Consumption of specific sources and adequate doses of n-3 PUFA for gout flare prevention warrants further study in an adequately powered clinical trial.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zhang M, Zhang Y, Terkeltaub R, et al. Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares. Arthritis Rheumatol. 2019. PMID: 30908893. doi:10.1002/art.40896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。